Columbus Macro’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Columbus Macro's PFE Position: Q4 2023 in Review
Columbus Macro sold out of Pfizer (PFE) in Q4 2023, closing a stake of 52,203 shares — an estimated $1.73M sold.
Columbus Macro first reported a position in PFE in Q4 2017 and held it in 24 quarters. The position peaked at $5.69M in Q3 2018. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- Columbus Macro reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
- Columbus Macro sold 52,203 Pfizer shares in Q4 2023, an estimated $1.73M.
- Columbus Macro first reported a position in Pfizer in Q4 2017 and held it in 24 quarters.
- Columbus Macro's Pfizer position peaked at $5.69M in Q3 2018.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on Columbus Macro's 13F filing for Q4 2023, filed 19 Jan 2024.